Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

MK Higashi, DL Veenstra, LM Kondo, AK Wittkowsky… - Jama, 2002 - jamanetwork.com
… Author Affiliations: Pharmaceutical Outcomes Research and Policy Program (Drs Higashi
and Veenstra), Institute for Public Health Genetics (Dr Veenstra), and Department of Pharmacy …

[HTML][HTML] Applying dynamic simulation modeling methods in health care delivery research—the SIMULATE checklist: report of the ISPOR simulation modeling emerging …

…, MJ IJzerman, ND Osgood, WV Padula, MK Higashi… - Value in health, 2015 - Elsevier
Health care delivery systems are inherently complex, consisting of multiple tiers of
interdependent subsystems and processes that are adaptive to changes in the environment and …

Feasibility of an online mindfulness program for stress management—a randomized, controlled trial

…, D Allexandre, E Fox, AZ Fu, MK Higashi… - Annals of behavioral …, 2013 - academic.oup.com
Background Chronic stress affects many Americans. Stress management programs may be
prohibitively expensive or have limited access. Purpose This study aims to determine …

[HTML][HTML] Selecting a dynamic simulation modeling method for health care delivery research—Part 2: Report of the ISPOR dynamic simulation modeling emerging good …

…, WV Padula, PK Wong, KS Pasupathy, MK Higashi… - Value in health, 2015 - Elsevier
In a previous report, the ISPOR Task Force on Dynamic Simulation Modeling Applications in
Health Care Delivery Research Emerging Good Practices introduced the fundamentals of …

Assessing the cost-effectiveness of pharmacogenomics

DL Veenstra, MK Higashi, KA Phillips - Aaps Pharmsci, 2000 - Springer
The use of pharmacogenomics to individualize drug therapy offers the potential to improve
drug effectiveness, reduce adverse side effects, and provide cost-effective pharmaceutical …

CYP2C9 Haplotype Structure in European American Warfarin Patients and Association with Clinical Outcomes

DL Veenstra, DK Blough, MK Higashi… - Clinical …, 2005 - Wiley Online Library
Objective The goal of this study was to define the haplotype structure of the cytochrome P450
(CYP) 2C9 gene in a European American population and evaluate associations between …

Transforming healthcare delivery: integrating dynamic simulation modelling and big data in health economics and outcomes research

…, WV Padula, MJ IJzerman, PK Wong, MK Higashi… - …, 2016 - Springer
In the era of the Information Age and personalized medicine, healthcare delivery systems
need to be efficient and patient-centred. The health system must be responsive to individual …

The quality of life impact of acute exacerbations of chronic bronchitis (AECB): a literature review

JK Schmier, MT Halpern, MK Higashi, A Bakst - Quality of life research, 2005 - Springer
Background: The impact of acute exacerbations of chronic bronchitis (AECB), a common
consequence of chronic obstructive pulmonary disease (COPD), is extensive, with symptoms …

[PDF][PDF] Managed care in the genomics era: assessing the cost effectiveness of genetic tests

MK Higashi, DL Veenstra - Am J Manag Care, 2003 - ajmc.s3.amazonaws.com
AJMC July*Higashi 493-500 Page 1 With the completion of the Human Genome Project,
researchers are seeking ways to translate genetic information into clinical applications. …

Health economic evaluation of non-melanoma skin cancer and actinic keratosis

MK Higashi, DL Veenstra, PC Langley - Pharmacoeconomics, 2004 - Springer
Non-melanoma skin cancer (NMSC) and actinic keratosis are becoming an increasingly
important healthcare problem. There are approximately 1 million cases of NMSC in the US each …